Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Total Liabilities (2018 - 2025)

TELA Bio (TELA) has 8 years of Total Liabilities data on record, last reported at $60.0 million in Q3 2025.

  • For Q3 2025, Total Liabilities rose 1.25% year-over-year to $60.0 million; the TTM value through Sep 2025 reached $60.0 million, up 1.25%, while the annual FY2024 figure was $58.1 million, 1.78% down from the prior year.
  • Total Liabilities reached $60.0 million in Q3 2025 per TELA's latest filing, up from $58.4 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $60.0 million in Q3 2025 and bottomed at $36.6 million in Q1 2021.
  • Average Total Liabilities over 5 years is $52.8 million, with a median of $56.3 million recorded in 2022.
  • Peak YoY movement for Total Liabilities: surged 36.96% in 2022, then fell 1.78% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $42.4 million in 2021, then increased by 26.16% to $53.6 million in 2022, then rose by 10.49% to $59.2 million in 2023, then fell by 1.78% to $58.1 million in 2024, then grew by 3.3% to $60.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $60.0 million in Q3 2025, $58.4 million in Q2 2025, and $59.1 million in Q1 2025.